Publication | Closed Access
Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12-Week Open-Label Trial
68
Citations
34
References
2006
Year
In our patient population, treatment of superficial BCCs with topical imiquimod for 12 weeks produced an excellent clinical response overall, with complete remission maintained after a mean of 23 months.
| Year | Citations | |
|---|---|---|
Page 1
Page 1